Dr. Thomas H. Openshaw
Claim this profileCape Cod Hospital
Studies Breast Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
8 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
ER negative
2Non-Small Cell Lung Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Thomas H. Openshaw is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Thomas H. Openshaw
Clinical Trial Related9 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Thomas H. Openshaw has experience with
- Abemaciclib
- Regional Nodal XRT
- Chestwall XRT
- WBI
- Biospecimen Collection
- Crizotinib
Breakdown of trials Thomas H. Openshaw has run
Breast Cancer
Non-Small Cell Lung Cancer
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas H. Openshaw specialize in?
Thomas H. Openshaw focuses on Breast Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Thomas H. Openshaw currently recruiting for clinical trials?
Yes, Thomas H. Openshaw is currently recruiting for 3 clinical trials in Hyannis Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Thomas H. Openshaw has studied deeply?
Yes, Thomas H. Openshaw has studied treatments such as Abemaciclib, Regional Nodal XRT, Chestwall XRT.
What is the best way to schedule an appointment with Thomas H. Openshaw?
Apply for one of the trials that Thomas H. Openshaw is conducting.
What is the office address of Thomas H. Openshaw?
The office of Thomas H. Openshaw is located at: Cape Cod Hospital, Hyannis, Massachusetts 02601 United States. This is the address for their practice at the Cape Cod Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.